Ozempic vs Wegovy vs Mounjaro — Muscle Risk Compared

Ozempic and Wegovy contain the same active ingredient—semaglutide—but they're approved for different uses and titrated on different schedules. Mounjaro and Zepbound both contain tirzepatide, with the same split: type 2 diabetes vs chronic weight management. For muscle retention, how fast you ramp dose and lose weight matters more than the brand name on the pen.

Side-by-side comparison

What the evidence suggests

Clinical trials across semaglutide and tirzepatide brands show lean mass as a fraction of total weight lost. DXA substudies report roughly 25–40% of weight lost as lean tissue, varying by trial and dose—neither formulation is "muscle-sparing" by itself. Users on higher effective doses who lose weight faster without resistance training tend to report more strength and facial-volume concerns.

Practical takeaway

If you're on either medication:

1. Match protein to your current weight, not your goal weight
2. Log strength (reps, weights, or band tension)—not just lbs on the scale
3. Use medication-aware protocols that account for injection day appetite patterns

GlowsProtocol supports Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1/GIP options in one assessment.